Large Indian Pharmas Join With Foreign Firms To Develop NCEs
This article was originally published in PharmAsia News
Executive Summary
Several leading Indian pharmaceutical companies have joined with foreign firms in a three-year effort to develop new chemical entities. Indian companies include Jubilant Organosys, Nicholas Piramal, Orchid Chemicals and Zydus Cadia. The Indian and foreign companies seek to combine their technology, talent and cost benefits to develop new drugs. Foreign firms see Indian firms as only in the early stages of entering the arena of research for drug discovery. (Click here for more